Respiratory patent battle continues with ResMed against BMC Medical

August 22, 2013 by Arezu Sarvestani

California respiratory devices maker ResMed petitions an International Trade Commission investigation against yet another foreign rival, this time targeting China's BMC Medical and its Florida distributors.

Respiratory patent battle continues with ResMed against BMC Medical

California medical device maker ResMed (NYSE:RMD) is taking another swing at Chinese respiratory technology rival BMC Medical, getting the International Trade Commission's cooperation in an investigation into potential patent infringement.

ResMed has challenged BMC before, suing the company and its Florida distributors, 3B Medical Inc. and 3B Product, for allegedly violating patents for respiratory and sleep-disordered breathing devices. ResMed hopes to land an ITC ruling that would prevent BMC's infringing products from entering the U.S.

Sign up to get our free newsletters delivered right to your inbox.

"We're encouraged by the ITC's action to investigate this case against BMC," ResMed global general counsel and chief administrative officer David Pendarvis said in prepared remarks. "We invest over $100 million in research and development each year to fuel these advances and other companies should not be allowed to infringe ResMed's intellectual property by using our technology."